Study details
Enrolling now
Intra-articular Platelet-Rich Plasma vs. Viscosupplementation for Knee Osteoarthritis
Endeavor Health
NCT IDNCT03491761ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
100
Study length
about 9.6 years
Ages
18–75
Locations
1 site in IL
What this study is about
Researchers are testing whether platelet-rich plasma (PRP) is more effective than hyaluronic acid (HA) in treating knee osteoarthritis. The trial will measure changes in cartilage thickness and pain/function using the KOOS questionnaire to compare PRP and HA treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive HA Treatment
- 2.Receive PRP Treatment
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Cartilage Thickness on MRI
Body systems
Musculoskeletal